Patents for C12P 21 - Preparation of peptides or proteins (112,499)
07/2002
07/18/2002WO2002029088A3 Highly expressible genes
07/18/2002WO2002028351A3 Recombinant mucin binding proteins from steptococcus pneumoniae
07/18/2002WO2002022776A3 Human coagulation factor vii variants
07/18/2002WO2002012535B1 Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotherapy
07/18/2002WO2002010411A3 Preparation of a recombinant protein in a prokaryotic host cell by improved codon use
07/18/2002WO2002006316A3 Alpha-msh related compounds and methods of use
07/18/2002WO2002006311A3 Olfactory g-protein coupled receptor
07/18/2002WO2002002633A3 Transporters and ion channels
07/18/2002WO2001094391A3 Intracellular signaling proteins
07/18/2002WO2001088132A3 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods
07/18/2002WO2001087980A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
07/18/2002WO2001085798A3 Human monoclonal antibodies to dendritic cells
07/18/2002WO2001085790A3 Mammalian cytokine receptor subunit proteins, related reagents and methods
07/18/2002WO2001083749A3 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
07/18/2002WO2001083525A3 Modified peptides, comprising an fc domain, as therapeutic agents
07/18/2002WO2001081590A3 Protein phosphatases
07/18/2002WO2001081544A3 Identification and uses of a hyaluronan receptor
07/18/2002WO2001081408A3 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
07/18/2002WO2001081377A3 Integrin/adhesion antagonists
07/18/2002WO2001079468A3 Drug metabolizing enzymes
07/18/2002WO2001079282A3 Molecules associated with human reproduction
07/18/2002WO2001072822A3 Genes involved in intestinal inflammatory diseases and use thereof
07/18/2002WO2001068705A3 Il-17 receptor like molecules and uses thereof
07/18/2002WO2001051520A9 Nogo receptor-mediated blockade of axonal growth
07/18/2002WO2001005834A9 Human tumor necrosis factor receptors tr13 and tr14
07/18/2002WO2000078972A9 Regulation with binding cassette transporter protein abc1
07/18/2002WO2000076310A9 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
07/18/2002US20020095027 Polypeptide for use in the diagnosis and treatment of viral diseases in animals
07/18/2002US20020095024 B7-related nucleic acids and polypeptides useful for immunomodulation
07/18/2002US20020094967 Polynucleotide
07/18/2002US20020094955 Plasminogen-like polynucleotides, polypeptides, and antibodies
07/18/2002US20020094954 Nucleic acids comprising the neuregulin-1-associated gene 1 (NRG1AG1)
07/18/2002US20020094953 Nucleic acids, proteins, and antibodies
07/18/2002US20020094530 Method to identify antibody targets
07/18/2002US20020094340 Chlamydia antigens and corresponding dna thereof
07/18/2002DE10123857A1 Verfahren zum Herstellen von heterologen Proteinen in einem homothallischen Pilz der Familie Sordariaceae A method for producing heterologous proteins in a homothallic fungus of the family Sordariaceae
07/18/2002CA2436876A1 Transcriptional mediators of blood vessel development and endothelial differentiation
07/18/2002CA2434042A1 Asip-related proteins
07/18/2002CA2433742A1 Proteins and nucleic acids encoding same
07/18/2002CA2433687A1 Soluble cyclic analogues of beta amyloid peptide
07/18/2002CA2430794A1 Human genes and gene expression products isolated from human prostate
07/18/2002CA2429946A1 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c
07/17/2002EP1223214A1 Gene encoding novel human secretory phospholipase a 2?
07/17/2002EP1222314A1 Human antibodies
07/17/2002EP1222307A1 A pcam-1 marker protein, nucleic acid sequences encoding pcam-1 and immunoassays for detection of pcam-1
07/17/2002EP1222301A2 Protein production system
07/17/2002EP1222298A1 Vectors and methods for recombinant protein expression
07/17/2002EP1222286A2 Aortic carboxypeptidase-like protein and nucleic acids encoding same
07/17/2002EP1222281A2 Immunoligically significant herpes simplex virus antigens
07/17/2002EP1222279A2 Growth factor polypeptides and nucleic acids encoding same
07/17/2002EP1222277A2 Endozepine-like polypeptides and polynucleotides encoding same
07/17/2002EP1222276A2 Polynucleotides and polypeptides encoded thereby
07/17/2002EP1222275A2 Serum amyloid a isoform from colostrum
07/17/2002EP1222274A2 Mage-a12 antigenic peptides and uses thereof
07/17/2002EP1222273A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same
07/17/2002EP1222270A2 Proteins and polynucleotides encoded thereby
07/17/2002EP1222268A2 Vip54 protein and related materials
07/17/2002EP1222267A2 Pcna-associated cell cycle proteins, compositions and methods of use
07/17/2002EP1222264A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof
07/17/2002EP1222253A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies
07/17/2002EP1222211A1 Pcna associated cell cycle proteins, compositions and methods of use
07/17/2002EP1222208A1 Polypeptide derivatives of parathyroid hormone (pth)
07/17/2002EP1222207A1 C-peptide for the improved production of insulin and insulin analogues
07/17/2002EP1222202A2 Ab5 toxin b subunit mutants with altered chemical conjug ation characteristics
07/17/2002EP1221853A1 Oligodendrocyte cell cultures and methods for their preparation and use
07/17/2002EP0815450B1 Compounds and methods for the dectection of t. cruzi infection
07/17/2002EP0804219B1 Inhibin compositions and methods of use thereof
07/17/2002CN1359424A Pesticidal fusions
07/17/2002CN1359420A Novel indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals
07/17/2002CN1359388A Method for enhanced protein stabilization and production of cell liell lines useful for production of such stabilized proteins
07/17/2002CN1359298A Novel indications of mannan-bindie lectin (MBL) in the treatment of immanocompromised individuals
07/16/2002US6420542 Tie ligands
07/16/2002US6420540 Toxoplasma gondii antigens
07/16/2002US6420532 Binding to human y2 receptors and expression
07/16/2002US6420531 Polypeptides prepared by expressing in a host cell a dna code with amino acid sequence
07/16/2002US6420530 Polymaleic acid polymer or copolymer with acrylic acid, maleic anhydride, ethyl acrylate or vinyl acetate
07/16/2002US6420525 Human transcription factor ZGCL-1
07/16/2002US6420380 Hepatitis C inhibitor tri-peptides
07/16/2002US6420353 Use of 7 α-substituted steroid to treat neuropsychiatric, immune or endocrine disorders
07/16/2002US6420336 Purified antiviral protein, peptide or conjugate encoded by amino acid sequence 90% homologous to seq id no: 2; prophy-lactic or therapeutic inhibition of growth of a virus, such as a retrovirus; human immunodeficiency virus, hiv-1 or hiv-2
07/16/2002US6420175 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
07/16/2002US6420157 Expression vector coding enzymatic polypeptide for use in the treatment of inflammation and sexual disorders; for use in laundry detergents
07/16/2002US6420155 Polypeptide for use in the treatment of cancer and atherosclerosis
07/16/2002US6420152 Bacterial enzymatic polypeptide for use in detection of infection
07/16/2002US6420140 Production of multimeric protein by cell fusion method
07/16/2002US6420135 Streptococcus pneumoniae polynucleotides and sequences
07/16/2002US6420134 Vaccines for nontypable haemophilus influenzae
07/16/2002US6420124 KVLQT1—a long qt syndrome gene
07/16/2002US6420113 Chimeric polyclonal antibodies
07/16/2002US6419929 Genetic engineering
07/16/2002US6419928 Monoclonal antibodies to transforming growth factor-beta and methods of use
07/16/2002US6419925 Toxoplasma gondii antigens, the preparation thereof and the use thereof
07/16/2002US6419921 DNA-constructs of blood clotting factors and P-Selectin
07/16/2002US6419918 Receptors of chemotactic peptide; leukemia therapy
07/16/2002CA2239360C G-csf analog compositions and methods
07/16/2002CA2193094C The cytoplasmic inhibition of gene expression
07/16/2002CA2097200C Protein tyrosine kinase
07/16/2002CA2095926C Anti-human milk fat globule humanised antibodies
07/16/2002CA2059242C Coleopteran-active bacillus thuringiensis isolate and a novel gene encoding a coleopteran-active toxin
07/16/2002CA2024063C Antibodies directed against nerve growth factor-like peptides